?
Johnson Lloyd Emerson
Director
Apogee Enterprises, Inc.
US, Minneapolis [HQ]
CIK
1708823
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
260
Price per Share :
$54.69
Equivalence :
$14,219.40
Transaction History
-
S260 Shares After TransactionValue : $16,413.80Sold $1,515,120.00Transaction Date : 05/02/24
-
Footnotes
-
-
Footnotes:#1 The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $62.39 to $63.88. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.
-
A6,706 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/02/25
-
Footnotes
-
-
Footnotes:#1 Represents shares issued as part of the annual compensation for service as a director.
-
A10,240 Shares After TransactionValue : $n/a$0.0Transaction Date : 07/25/24
-
Footnotes
-
-
Footnotes:#1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.#2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
-
A5,252 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/02/24
-
Footnotes
-
-
Footnotes:#1 Represents shares issued as part of the annual compensation for service as a director.